摘要
目的观察低分子肝素(LMWH)对慢性阻塞性肺疾病(COPD)大鼠模型肺组织基质金属蛋白酶-9(MMP-9)及组织金属蛋白酶抑制物-1(TIMP-1)表达的影响,探讨其对COPD可能的干预机制。方法随机将30只Wistar大鼠分成3组,每组10只。对照组大鼠正常饲养40 d,不做任何干预;COPD模型组大鼠用香烟染毒加气管内注入脂多糖法建立COPD模型并给予生理盐水皮下注射,每天1次;LMWH干预组大鼠造模后给予低分子肝素150 U/kg皮下注射,每天1次,治疗40 d。观察3组血气、肺组织病理学改变,采用免疫组织化学法检测肺组织MMP-9和TIMP-1表达。结果LMWH干预组大鼠肺组织的病理改变程度减轻,MMP-9表达减少,其阳性面积及MMP-9/TIMP-1与COPD模型组比较差异有显著意义(F=6.39、56.04,q=26.72、3.34,P<0.01)。结论LMWH可能通过调节MMP-9、TIMP-1表达,减轻肺气肿时肺泡壁破坏过程中细胞外基质的降解,发挥治疗COPD的作用。
Objective To observe the effects of low molecular heparin (LMH) on expressions of matrix metalloproteinase-9 (MMP 9) and tissue inhibitors of metalloproteinase-1 (TIMP-1) in lung tissue of Wistar rats with chronic obstructive pulmonary disease (COPD) and the possible intervention mechanism of this condition. Methods Thirty Wistar rats were equally randomized to control group: normally raised for 40 days without any interference; COPD model group: cigarette inhalation plus intratracheal instillation of lipopolysaccharide and hypodermic injection of normal saline, once a day; LMH group: LMH, 150 U/kg, hypodermic injection, once a day for 40 days. Blood gas, histology of lung tissue, and MMP-9/TIMP-1 expressions were examined. Results Pathological changes of the lung tissue in LMH decreased, compared with COPD model group, the diffe rences of expression of MMP 9 and the ratio of MMP-9/TIMP-1 were significantly different (F= 6.39,56.04;q-26.72,3.34;P〈0.01). Conclusion Low molecular heparin educes its effect on therapy of COPD probably by regulating the expressions of MMP 9 and TIMP-1, lessening the degradation of extracellular matrix in the process of destruction of extracellular matrix of alveolar wall when emphysema happened.
出处
《青岛大学医学院学报》
CAS
2009年第5期430-432,共3页
Acta Academiae Medicinae Qingdao Universitatis
基金
青岛市科技局计划课题(06-2-2-3-nsh-5)
关键词
肺疾病
慢性阻塞性
肝素
低分子量
明胶酶B
组织金属蛋白酶抑制物-1
Pulmonary disease, chronic obstructive
Heparin, low-molecula
weight
Gelatinase B
Tissue inhibitors of metalloproteinase- 1